Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy
- PMID: 24687675
- PMCID: PMC6018050
- DOI: 10.1183/09031936.00015314
Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy
Conflict of interest statement
Conflict of interest: None declared.
Comment on
-
Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy.Eur Respir J. 2013 Aug;42(2):350-61. doi: 10.1183/09031936.00042512. Epub 2012 Nov 22. Eur Respir J. 2013. PMID: 23180589 Free PMC article.
-
Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy.Eur Respir J. 2014 Apr;43(4):1208-11. doi: 10.1183/09031936.00099913. Eur Respir J. 2014. PMID: 24687674 No abstract available.
References
-
- Murphy DM, Forrest IA, Corris PA, et al. Simvastatin attenuates release of neutrophilic and remodeling factors from primary bronchial epithelial cells derived from stable lung transplant recipients. Am J Physiol Lung Cell Mol Physiol. 2008;294:592–599. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical